Real Chemistry Expands Partnership with Datavant to Connect Proprietary Pharmaceutical Data to Real-World Data to Accelerate Precision Medicine forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Indapta Therapeutics Announces Key Management Team Appointments to Advance into Clinical Trials in 2021
February 3, 2021 GMT
SAN FRANCISCO (BUSINESS WIRE) Feb 3, 2021
Indapta Therapeutics Inc. (“Indapta”), a biotechnology company focused on developing and commercializing a proprietary, first-in-class, off-the-shelf, non-engineered, allogeneic FcRγ-deficient natural killer (G-NK) cell therapy to treat multiple cancers, today announced the appointments of Lori Kunkel, M.D., as its Senior Clinical Advisor, Robert Sikorski, M.D., Ph.D., as its Founding Chief Medical Officer, and Jim Weiss as a member of its Board of Directors.
Cellares ajoute PACT Pharma à son programme de partenariat d accès rapide prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Cellares Adds PACT Pharma to its Early Access Partnership Program
USA - English
- Under the partnership, PACT Pharma will provide the company with insight into autologous NeoTCR manufacturing workflows to help identify product-market fit and secure early access to the technology for an undisclosed amount
- PACT Pharma is the second organization and first industry partner to join the program following Fred Hutchinson Cancer Research Center
News provided by
Share this article
SOUTH SAN FRANCISCO, Jan. 8, 2021 /PRNewswire/
Cellares Corporation, a company focused on revolutionizing cell therapy manufacturing, announced that PACT Pharma, Inc., a clinical-stage company developing transformational personalized NeoTCR-T cell therapies for the eradication of solid tumors, has joined its Early Access Partnership Program (EAPP). PACT Pharma is the second collaborator and first industry organization to join its EAPP, following Fred Hutchinson Cancer Research Center. Under the terms of
Cellares añade a PACT Pharma a su programa de asociación de acceso temprano prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.